← Back to Search

Cognitive Behavioral Therapy

Cognitive Behavioral Therapy for Borderline Personality Disorder

N/A
Waitlist Available
Led By Shannon Sauer-Zavala
Research Sponsored by Shannon E. Sauer-Zavala
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
medication instability
previously received more than 5 sessions of cognitive behavioral therapy in the past 5 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 44 weeks (baseline, post-treatment/waitlist, 6 month follow-up)
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new cognitive-behavioral treatment for borderline personality disorder that is shorter and less intense than existing treatments. The hope is that this will be more effective for the majority of people with BPD who don't have severe symptoms.

Who is the study for?
This trial is for individuals diagnosed with borderline personality disorder (BPD) who haven't had extensive cognitive behavioral therapy in the past. It's not suitable for those currently receiving other psychotherapies, those with unstable medication regimens, or if they have psychological conditions that need different treatments.
What is being tested?
The study tests a new type of cognitive-behavioral therapy tailored to BPD patients without life-threatening behaviors. The treatment considers individual personality traits and aims to be shorter and less intensive than existing therapies.
What are the potential side effects?
As this is a psychological therapy trial, traditional 'side effects' are not applicable like in drug trials. Participants may experience emotional discomfort discussing personal issues but support will be provided throughout.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My medication doses have been stable recently.
Select...
I have had over 5 cognitive behavioral therapy sessions in the last 5 years.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~44 weeks (baseline, post-treatment/waitlist, 6 month follow-up)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 44 weeks (baseline, post-treatment/waitlist, 6 month follow-up) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Anxiety Symptoms
Change in Depressive Symptoms
Change in clinician-rated borderline personality disorder symptoms
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Waitlist/Delayed TreatmentExperimental Treatment1 Intervention
Participants in this group will receive the intervention after an 18-week wait.
Group II: Immediate TreatmentExperimental Treatment1 Intervention
Participants in this group will receive the intervention immediately.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Personality-Based Cognitive Behavioral Therapy
2020
N/A
~100

Find a Location

Who is running the clinical trial?

Shannon E. Sauer-ZavalaLead Sponsor
4 Previous Clinical Trials
296 Total Patients Enrolled
1 Trials studying Borderline Personality Disorder
30 Patients Enrolled for Borderline Personality Disorder
Shannon Sauer-ZavalaPrincipal InvestigatorUniversity of Kentucky
2 Previous Clinical Trials
138 Total Patients Enrolled

Media Library

Personality-Based Cognitive Behavioral Therapy (Cognitive Behavioral Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT04587518 — N/A
Borderline Personality Disorder Research Study Groups: Immediate Treatment, Waitlist/Delayed Treatment
Borderline Personality Disorder Clinical Trial 2023: Personality-Based Cognitive Behavioral Therapy Highlights & Side Effects. Trial Name: NCT04587518 — N/A
Personality-Based Cognitive Behavioral Therapy (Cognitive Behavioral Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04587518 — N/A
~19 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top